Press Releases
- Amgen Presents Open-Label Extension Data From Ongoing Phase 2 Study Of AMG 334 In The Prevention Of Episodic Migraine
- Acorda Presents Data on Inhaled Levodopa Therapy CVT-301 at International Congress of Parkinson's Disease and Movement Disorders
- Cynvenio Biosystems Announces $25.5 million Series B Financing
- Organovo Holdings, Inc. Prices $40 Million Public Offering of Common Stock
- AirXpanders Raises $36.5 Million in Oversubscribed IPO; Strong Institutional Support; to List on ASX on Monday
- More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.

